title: Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all?
authors.affiliation: Radiation Oncology Branch, Center for Cancer Research, 10 CRC, B2-3500, 10 Center Drive, Bethesda, MD 20892, USA. citrind@mail.nih.gov.
authors.forename: Deborah
authors.initials: D
authors.lastname: Citrin
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Camphausen
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000652:urine*; D006801:Humans; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers